Do you want to read an article? Please log in or register.
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study
J Crohns Colitis
Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J
doi: 10.1093/ecco-jcc/jjae192
Inflammatory Bowel Disease
Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study
Clin Gastroenterol Hepatol
Cosquer GL, Kirchgesner J, Joseph CGS, Seksik P, Amiot A, Laharie D, Nachury M, Rouillon C, Abitbol V, Nuzzo A, Nancey S, Fumery M, Biron A, Richard N, Altwegg R, Moussata D, Caron B, Vidon M, Reenaers C, Uzzan M, Jean-Marie R, Serrero M, Simon M, Benezech A, Goutorbe F, Anne-Laure P, Caillo L, Vaysse C, Poullenot F, getaid
doi: 10.1016/j.cgh.2024.09.034
Inflammatory Bowel Disease
Increased medication utilization precedes incidentally diagnosed inflammatory bowel disease: a multicenter, case-control study
Am J Gastroenterol
Rodríguez-Lago I, Aguirre U, Cabriada JL, Ungaro RC, Colombel JF, Acosta MB, Preclinical Basque Inflammatory Bowel Disease (PREBIBD) Study Group.
doi: 10.14309/ajg.0000000000003275
Inflammatory Bowel Disease
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis
J Crohns Colitis
D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S
doi: 10.1093/ecco-jcc/jjaf080
RECOMMENDED
Inflammatory Bowel Disease
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Calafat M, Suria C, Mesonero F, de Francisco R, Yagüe Caballero C, de la Peña L, Hernández-Camba A, Marcé A, Gallego B, Martín-Vicente N, Rivero M, Iborra M, Guerra I, Carrillo-Palau M, Madero L, Burgueño B, Monfort D, Torres G, Teller M, Ferrer Rosique JÁ, Vega Villaamil P, Roig C, Ponferrada-Diaz A, Betoré Glaría E, Zabana Y, Gisbert JP, Busquets D, Alcaide N, Camps B, Legido J, González-Vivo M, Bosca-Watts MM, Pérez-Martínez I, Casas Deza D, Guardiola J, Arranz Hernández L, Navarro M, Gargallo-Puyuelo CJ, Cañete F, Mañosa M, Domènech E, ENEIDA Registry of GETECCU
doi: 10.14309/ajg.0000000000002965
Inflammatory Bowel Disease
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort study
Clin Gastroenterol Hepatol
Honap S, Temido MJ, Shakweh E, Badrulhisham F, Shields N, Mehta S, McBride J, Uzzan M, Lukáš M, Fumery M, Nogami A, Kobayashi T, Nancey S, Neves JC, Mendes JM, Wegener BA, Bergereau E, Fernandes R, Kuriakose Kuzhiyanjal AJ, Vieujean S, Spencer A, Baillie S, Estevinho MM, Simão I, O'Neill C, Gututui M, Thompson E, Jama A, Chai N, Pavlidis P, D'Amico F, Limdi J, Magro F, Sebastian S, Digby-Bell J, Parkes GC, Din S, Hart A, Peyrin-Biroulet L, JAKne International Study Group
doi: 10.1016/j.cgh.2025.04.031
Inflammatory Bowel Disease
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study
Inflamm Bowel Dis
Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA
doi: 10.1093/ibd/izae147
Inflammatory Bowel Disease
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU
Gut
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M, EXIT Study group of GETECCU
doi: 10.1136/gutjnl-2024-333385
Inflammatory Bowel Disease
HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry
Am J Gastroenterol
Calafat M, Suria C, Mesonero F, de Francisco R, Caballero CY, Peña L, Hernández-Camba A, Marcé A, Gallego B, Martín-Vicente N, Rivero M, Iborra M, Guerra I, Carrillo-Palau M, Madero L, Burgueño B, Monfort D, Torres G, Teller M, Ferrer Rosique JÁ, Villaamil PV, Roig C, Ponferrada-Diaz A, Glaría EB, Zabana Y, Gisbert JP, Busquets D, Alcaide N, Camps B, Legido J, González-Vivo M, Bosca-Watts MM, Pérez-Martínez I, Deza DC, Guardiola J, Hernández LA, Navarro M, Gargallo-Puyuelo CJ, Cañete F, Mañosa M, Domènech E, ENEIDA registry of GETECCU
doi: 10.14309/ajg.0000000000002965